ERRT for Bipolar Disorder
(BERRT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new therapy called Exposure, Relaxation, and Rescripting Therapy (ERRT) to assist people with bipolar disorder who experience frequent nightmares and sleep disturbances. The goal is to determine if ERRT can reduce the frequency and intensity of nightmares and enhance sleep quality. The trial seeks participants who have experienced nightmares at least once a week for the past month, have bipolar disorder, and encountered a traumatic event more than a month ago. Participants should have been stable on their bipolar medication for at least two months. As an unphased trial, this study offers a chance to contribute to pioneering research that could improve sleep and quality of life for those with bipolar disorder.
Will I have to stop taking my current medications?
The trial requires that you have been stable on your bipolar medication for at least 2 months, so you will need to continue taking your current medications.
What prior data suggests that ERRT-Bipolar Disorder is safe for individuals with bipolar disorder?
Research has shown that Exposure, Relaxation, and Rescripting Therapy (ERRT) is generally well-received. Trials with non-military adults have proven that ERRT significantly reduces the frequency and severity of nightmares without causing serious side effects, suggesting the therapy is safe for most people.
Early studies are underway to confirm its safety and effectiveness for those with bipolar disorder. Although more research is needed to fully understand its impact on this group, ERRT has not been linked to major negative effects in other populations. Therefore, it appears to be a promising option for individuals dealing with ongoing nightmares and sleep problems.12345Why are researchers excited about this trial?
Researchers are excited about ERRT-Bipolar Disorder because it addresses sleep disturbances and trauma-related nightmares in bipolar disorder patients, which are often overlooked by standard treatments like mood stabilizers and antipsychotics. ERRT-Bipolar Disorder is unique in that it combines Exposure, Relaxation, and Rescripting Therapy in a focused, short-term format, consisting of just five weekly sessions. This therapy directly targets nightmares and sleep issues, which can significantly impact mood stability, offering a potentially faster and more targeted improvement in quality of life for those with bipolar disorder.
What evidence suggests that ERRT might be an effective treatment for bipolar disorder?
Research has shown that Exposure, Relaxation, and Rescripting Therapy (ERRT) can reduce the frequency and intensity of nightmares. It also appears to improve sleep quality for individuals who have experienced trauma. Although more research is needed specifically for those with bipolar disorder, early results suggest these benefits might also apply to them. In this trial, participants will receive ERRT-Bipolar Disorder, a variant of ERRT, as a weekly 5-session treatment aimed at reducing chronic trauma nightmares and sleep disturbances. ERRT uses mental imagery techniques to help manage upsetting thoughts, which is especially helpful for individuals with intrusive thoughts. These encouraging findings suggest that ERRT could be a useful treatment for nightmares and sleep problems in people with bipolar disorder.12567
Who Is on the Research Team?
Joanne L Davis, PhD
Principal Investigator
University of Tulsa
Are You a Good Fit for This Trial?
This trial is for adults with Bipolar Disorder (I or II) who have experienced a traumatic event over a month ago and suffer from frequent nightmares. Participants must be stable on bipolar medication for at least two months and not currently experiencing mania/hypomania, recent suicide attempts, hospitalizations, or untreated substance use disorders.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Exposure, Relaxation, and Rescripting Therapy (ERRT) for Bipolar disorder once a week for five consecutive weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 1-week, 3-months, and potentially 1-year
What Are the Treatments Tested in This Trial?
Interventions
- ERRT-Bipolar Disorder
ERRT-Bipolar Disorder is already approved in United States for the following indications:
- Trauma-related nightmares
- Sleep disturbances in trauma-exposed adults with bipolar disorder
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Tulsa
Lead Sponsor